Working Groups

Latest News

Dr Matthew Dryden on AMR

Executive Committee member Matthew Dryden discusses AMR.

Read More
Flu Survey: IPC Working ...

Please take the IPC Working Group survey on influenza.

Read More


Current Officers


Federico Pea

All Members

Christian Eckmann (Germany)
Evangelos J. Giamarellos-Bourboulis (Greece)
Ian Gould (UK)
Jian Li (Australia)
Teresita Mazzei (Italy)
Andrea Novelli (Italy)
Gianpaolo Perletti (Italy)
Francesco Scaglione (Italy)
Kazuhiro Tateda (Japan)
Ursula Theuretzbacher (Austria)
Paul M. Tulkens (Belgium)
Minggui Wang (China)
Florian Wagenlehner (Austria)


How to Join

Members of an ISAC Member Society are eligible to join any of our Working Groups. If you are a member and would like to join this group, please contact the Chairperson and Secretary (if applicable).

Aims and Objectives

Over the last 20 years, we assisted to an emerging crisis of antibiotic resistance for microbial pathogens throughout the world. At the very moment when increasing antimicrobial resistance has created the development of new antibiotics with novel mechanisms of action lacking. In this era the optimal use of old and eventually new antimicrobials became mandatory. The appropriate use of antimicrobials based on their pharmacological properties including pharmacokinetic/pharmacodynamics (PK/PD) relationship is one of the ways to achieve clinical success. By using pharmacological information researchers, regulators and clinicians can achieve the goal of maximal therapeutic effect while reducing the risks of drug exposure-related adverse events as well as the selection of resistance. While this is now more and more recognized by Academia, Industry and Regulatory Agencies, there is presently a lack of training into these disciplines. The same applies to other areas of development of anti-infectives such as antiviral, antifungal and antiprotozoal.

This Working Group aims to promote international exchange of ideas and new research into all aspects of antinfective pharmacology, also in collaboration with other scientific societies.

The Work Plan for the group is as follows - 

  • Organise a workshop on anti-infective pharmacology during the biannual ISC Congress
  • Organise occasional educational meetings
  • Encourage scientific exchange with other scientific organizations
  • Implement the PK/PD approach in anticancer chemotherapy
  • Apply for research grants


27-30 June 2015 Summer School on Anti-Infective Pharmacology, Italy
6-9 June 2013 Symposium for the 28th ICC in Yokohama, Japan
8-11 Nov 2012 Symposium at the 3rd SEEC in Dubrovnik, Croatia
November 2011 Symposium at the 2nd SEEC in Belgrade, Serbia
September 2010 Summer School on Anti-Infective Pharmacology, Palazzo Feltrinelli, Gargnano, Italy


Projects / Publications


Last updated: November 7th-2018